US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Terminated

Lisinopril Tablets USP

Reason Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.

Lupin Pharmaceuticals Inc. NDC 68180-980-03 D-1536-2022
Class II · Moderate risk Completed

Triamcinolone Acetonide cream

Reason CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.

Direct Rx NDC 72189-330-80 D-1535-2022
Class II · Moderate risk Terminated

Skincell Mole & Skin Corrector Serum

Reason Marketed Without An Approved NDA/ANDA; Unapproved new drug

Justified Laboratories D-0009-2023
Class II · Moderate risk Terminated

Skincell Mole & Skin Corrector Serum

Reason Marketed Without An Approved NDA/ANDA; Unapproved new drug

Justified Laboratories D-0008-2023
Class II · Moderate risk Terminated

Synergy Hand Sanitizer

Reason CGMP Deviations: FDA analysis found product to contain acetaldehyde impurity and the Sum of All Impurities, above specification limits.

Superior Glove Works, LTD. D-1537-2022
Class II · Moderate risk Terminated

Sodium Chloride Ophthalmic Ointment USP

Reason cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and products which potentially share the same root cause.

Akorn, Inc. NDC 17478-622-35 D-1496-2022
Class II · Moderate risk Terminated

Lidocaine Hydrochloride Jelly USP

Reason cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and products which potentially share the same root cause.

Akorn, Inc. NDC 17478-711-31 D-1495-2022
Class II · Moderate risk Terminated

Dextroamphetamine Saccharate

Reason Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually contained 100 tablets of 20 mg strength of the drug product.

Teva Pharmaceuticals USA Inc NDC 0555-0777-02 D-1539-2022
Class II · Moderate risk Completed

TRI-MIX 50/2.5/25 Injectable

Reason Lack of Assurance of Sterility

Carolina Infusion D-1532-2022
Class II · Moderate risk Completed

TRI-MIX 30/2/40 Injectable

Reason Lack of Assurance of Sterility

Carolina Infusion D-1531-2022
Class II · Moderate risk Completed

TRI-MIX 30/2/20 Injectable

Reason Lack of Assurance of Sterility

Carolina Infusion D-1530-2022
Class II · Moderate risk Completed

TRI-MIX 30/1/60 Injectable

Reason Lack of Assurance of Sterility

Carolina Infusion D-1529-2022
Class II · Moderate risk Completed

TRI-MIX 30/1/40 Injectable

Reason Lack of Assurance of Sterility

Carolina Infusion D-1528-2022
Class II · Moderate risk Completed

TRI-MIX 30/1/20 Injectable

Reason Lack of Assurance of Sterility

Carolina Infusion D-1527-2022
Class II · Moderate risk Completed

TRI-MIX 30/1/10 Injectable

Reason Lack of Assurance of Sterility

Carolina Infusion D-1526-2022
Class II · Moderate risk Completed

Test Cyp/Prop

Reason Lack of Assurance of Sterility

Carolina Infusion D-1525-2022
Class II · Moderate risk Completed

Test Cyp/Dhea

Reason Lack of Assurance of Sterility

Carolina Infusion D-1524-2022
Class II · Moderate risk Completed

Test Cyp/Dhea

Reason Lack of Assurance of Sterility

Carolina Infusion D-1523-2022
Class II · Moderate risk Completed

Test Cyp

Reason Lack of Assurance of Sterility

Carolina Infusion D-1522-2022